Talk Presenting Companies (Theatre A) track
Oncology: MEDiC Life Sciences
Mon, Nov 9, 2026 · 2:15–2:30 PM CET Koelnmesse
About this session
MEDiC Life Sciences is a clinical stage company leveraging millions of artificial biomarker combinations to advance novel cancer precision medicines with matched synthetic lethal biomarkers. We can rely on a growing proprietary data source of more than 1000 genome-wide CRISPR screens leveraging 3D cancer models and are advancing our lead asset, SLS-01, into a Phase 1B clinical trial in Q4 2026. To drive continued growth of our pipeline, we are launching the BEACON project, a collaboration with multiple biopharma companies to explore a "second life" for de-prioritized assets.
Speaker
-
CEO and Founder · MEDiC Life Sciences
Speaker